NICHOLAS WINCHESTER: Open Payments
NPI 1215589635 · SPRINGFIELD, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 62 payments from 13 companies in 2025. Trend: 2023 $1,101 · 2024 $1,310 · 2025 $1,583
Food & beverage: $1,583
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $616 |
| AstraZeneca Pharmaceuticals LP | 12 | $306 |
| ABBVIE INC. | 8 | $218 |
| PFIZER INC. | 8 | $129 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Corcept Therapeutics | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Astellas Pharma US Inc | 2 | $32 |
Products named: Ozempic, Rybelsus, QULIPTA, FARXIGA, Wegovy, AIRSUPRA, NURTEC ODT, XIFAXAN.
Industry payments across TN — which companies pay providers there.
